These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 6117)

  • 1. Dopamine metabolism in the mesolimbic and mesocortical dopaminergic systems after single or repeated administrations of neuroleptics.
    Scatton B; Glowinski J; Julou L
    Brain Res; 1976 Jun; 109(1):184-9. PubMed ID: 6117
    [No Abstract]   [Full Text] [Related]  

  • 2. [Metabolism of dopamine and norepinephrine in rat brain after acute and chronic administration of haloperidol, loxapine and clozapine].
    Bürki HR
    Arzneimittelforschung; 1974 Jul; 24(7):983-4. PubMed ID: 4136404
    [No Abstract]   [Full Text] [Related]  

  • 3. Mesocortical dopamine neurons: rapid transmitter turnover compared to other brain catecholamine systems.
    Bannon MJ; Bunney EB; Roth RH
    Brain Res; 1981 Aug; 218(1-2):376-82. PubMed ID: 7272743
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of neuroleptics on the nigroneostriatal and mesocortical dopaminergic systems.
    Glowinski J
    Res Publ Assoc Res Nerv Ment Dis; 1975; 54():233-46. PubMed ID: 769114
    [No Abstract]   [Full Text] [Related]  

  • 5. Receptor activity and turnover of dopamine and noradrenaline after neuroleptics.
    Andén NE; Butcher SG; Corrodi H; Fuxe K; Ungerstedt U
    Eur J Pharmacol; 1970; 11(3):303-14. PubMed ID: 5477307
    [No Abstract]   [Full Text] [Related]  

  • 6. Morphine stimulation of mesolimbic and mesocortical but not nigrostriatal dopamine release in the rat as reflected by changes in 3-methoxytyramine levels.
    Wood PL; Rao TS
    Neuropharmacology; 1991 Apr; 30(4):399-401. PubMed ID: 1852270
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characteristics of dopamine and beta-adrenergic sensitive adenylate cyclases in the frontal cerebral cortex of the rat. Comparative effects of neuroleptics on frontal cortex and striatal dopamine sensitive adenylate cyclases.
    Bockaert J; Tassin JP; Thierry AM; Glowinski J; Premont J
    Brain Res; 1977 Feb; 122(1):71-86. PubMed ID: 837225
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dopamine and norepinephrine enhancement in discrete rat brain regions following neonatal 6-hydroxydopamine treatment.
    Oke A; Keller R; Adams RN
    Brain Res; 1978 Jun; 148(1):245-50. PubMed ID: 656929
    [No Abstract]   [Full Text] [Related]  

  • 9. Effects of thioproperazine and apomorphine on dopamine synthesis in the mesocortical dopaminergic systems.
    Scatton B; Thierry AM; Glowinski J; Julou L
    Brain Res; 1975 May; 88(2):389-93. PubMed ID: 238717
    [No Abstract]   [Full Text] [Related]  

  • 10. Discovery of the mesocortical dopaminergic system: some pharmacological and functional characteristics.
    Thierry AM; Tassin JP; Blanc G; Stinus L; Scatton B; Glowinski J
    Adv Biochem Psychopharmacol; 1977; 16():5-12. PubMed ID: 883554
    [No Abstract]   [Full Text] [Related]  

  • 11. Changes in catecholamine concentrations and synthesis rate in mouse brain during the 'supersensitivity' phase after treatment with neuroleptic drugs.
    Hyttel J; Moller Nielsen I
    J Neurochem; 1976 Jul; 27(1):313-5. PubMed ID: 956841
    [No Abstract]   [Full Text] [Related]  

  • 12. The neuroleptics. 6. Clinical and experimental electroencephalography.
    Borenstein P; Dongier M; Fink M; Florio V; Itil TM; Longo VG; Mellerio F; Naquet R; Pampiglione G; Titeca J; Verdeaux G
    Mod Probl Pharmacopsychiatry; 1970; 5():109-25. PubMed ID: 5005609
    [No Abstract]   [Full Text] [Related]  

  • 13. Role of dopamine and norepinephrine in the chemistry of reward.
    Fibiger HC; Phillips AG
    J Psychiatr Res; 1974; 11():135-43. PubMed ID: 4461785
    [No Abstract]   [Full Text] [Related]  

  • 14. Catecholamine innervation of the basal forebrain. III. Olfactory bulb, anterior olfactory nuclei, olfactory tubercle and piriform cortex.
    Fallon JH; Moore RY
    J Comp Neurol; 1978 Aug; 180(3):533-44. PubMed ID: 307009
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of stress and ACTH on dopamine metabolism in the nucleus accumbens and frontal cortex.
    Fadda F; Liguori G
    Boll Soc Ital Biol Sper; 1981 Feb; 57(4):454-8. PubMed ID: 6263300
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Minor tranquillizers, stress and central catecholamine neurons.
    Corrodi H; Fuxe K; Lidbrink P; Olson L
    Brain Res; 1971 Jun; 29(1):1-16. PubMed ID: 5564261
    [No Abstract]   [Full Text] [Related]  

  • 17. Biochemical mapping of the noradrenergic ventral bundle projection sites: evidence for a noradrenergic--dopaminergic interaction.
    O'Donohue TL; Crowley WR; Jacobowitz DM
    Brain Res; 1979 Aug; 172(1):87-100. PubMed ID: 466469
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The activity of some neuroleptic drugs and amphetamine in normal and isolated rats.
    Kostowski W; Czlonkowski A
    Pharmacology; 1973; 10(2):82-7. PubMed ID: 4797045
    [No Abstract]   [Full Text] [Related]  

  • 19. Histological and molecular biochemistry.
    Andén NE; Bartholini G; Corrodi H; Csillik B; De Robertis E; Dresse A; Fuxe K; Gerebtzoff MA; Glowinski J; Hansson E; Hökfelt T; Renson J; Roos BE
    Mod Probl Pharmacopsychiatry; 1970; 5():1-11. PubMed ID: 4348145
    [No Abstract]   [Full Text] [Related]  

  • 20. Psychotropic drugs and dopamine uptake inhibition.
    Halaris AE; Freedman DX
    Res Publ Assoc Res Nerv Ment Dis; 1975; 54():247-58. PubMed ID: 3829
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.